Literature DB >> 8883365

Specific binding of polypyrimidine tract binding protein and hnRNP A1 to HIV-1 CRS elements.

A C Black, J Luo, S Chun, A Bakker, J K Fraser, J D Rosenblatt.   

Abstract

The human immunodeficiency virus (HIV) Rev and human T-cell leukemia virus (HTLV) Rex proteins regulate viral RNA processing. Both proteins act to overcome the block to viral structural gene expression, at least in part, by reversing the inhibitory effect of intronic RNA sequences, termed cis-acting repressive (CRS) sequences. Using HTLV type II (HTLV-II) as a model, we recently showed that the function of a 5' long terminal repeat (LTR) CRS correlates with in vitro binding by both polypyrimidine tract binding (PTB) protein (also known as hnRNP I) and hnRNP A1 to CRS RNA (1,2). Using radioimmunoprecipitation of proteins ultraviolet (UV) crosslinked to each HIV CRS RNA with monoclonal anti-hnRNP antibodies, we now demonstrate that hnRNP I and hnRNP A1 bind to two different HIV-1 CRS RNAs. In addition, we show that hnRNP I and hnRNP A1 binding to HIV-1 CRS RNAs can be specifically competed by HTLV-II CRS RNAs using electrophoretic mobility shift assay (EMSA)/UV crosslinking assays. Binding by both hnRNP I and hnRNP A1 to HIV-1 and HTLV-II CRS RNAs suggests a role for these proteins in CRS function that may be influenced by the Rev and Rex proteins, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883365     DOI: 10.1007/bf00284648

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  44 in total

1.  hnRNP I, the polypyrimidine tract-binding protein: distinct nuclear localization and association with hnRNAs.

Authors:  A Ghetti; S Piñol-Roma; W M Michael; C Morandi; G Dreyfuss
Journal:  Nucleic Acids Res       Date:  1992-07-25       Impact factor: 16.971

2.  Intragenic cis-acting art gene-responsive sequences of the human immunodeficiency virus.

Authors:  C A Rosen; E Terwilliger; A Dayton; J G Sodroski; W A Haseltine
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

3.  Cellular protein modulates effects of human immunodeficiency virus type 1 Rev.

Authors:  Y Luo; H Yu; B M Peterlin
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

4.  The basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assembly.

Authors:  J Kjems; P A Sharp
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

5.  Characterization of cDNAs encoding the polypyrimidine tract-binding protein.

Authors:  A Gil; P A Sharp; S F Jamison; M A Garcia-Blanco
Journal:  Genes Dev       Date:  1991-07       Impact factor: 11.361

6.  Interaction of polypyrimidine tract binding protein with the encephalomyocarditis virus mRNA internal ribosomal entry site.

Authors:  G W Witherell; A Gil; E Wimmer
Journal:  Biochemistry       Date:  1993-08-17       Impact factor: 3.162

7.  Rev is necessary for translation but not cytoplasmic accumulation of HIV-1 vif, vpr, and env/vpu 2 RNAs.

Authors:  S J Arrigo; I S Chen
Journal:  Genes Dev       Date:  1991-05       Impact factor: 11.361

8.  HTLV-1 rex and HIV-1 rev act through similar mechanisms to relieve suppression of unspliced RNA expression.

Authors:  M Itoh; J Inoue; H Toyoshima; T Akizawa; M Higashi; M Yoshida
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

9.  Interaction of cellular factors with intragenic cis-acting repressive sequences within the HIV genome.

Authors:  H S Olsen; A W Cochrane; C Rosen
Journal:  Virology       Date:  1992-12       Impact factor: 3.616

10.  Functional expression of cloned human splicing factor SF2: homology to RNA-binding proteins, U1 70K, and Drosophila splicing regulators.

Authors:  A R Krainer; A Mayeda; D Kozak; G Binns
Journal:  Cell       Date:  1991-07-26       Impact factor: 41.582

View more
  23 in total

1.  Integrated functional and bioinformatics approach for the identification and experimental verification of RNA signals: application to HIV-1 INS.

Authors:  Horst Wolff; Ruth Brack-Werner; Markus Neumann; Thomas Werner; Ralf Schneider
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

Review 2.  Transcriptional and posttranscriptional regulation of HIV-1 gene expression.

Authors:  Jonathan Karn; C Martin Stoltzfus
Journal:  Cold Spring Harb Perspect Med       Date:  2012-02       Impact factor: 6.915

Review 3.  Translation initiation of the HIV-1 mRNA.

Authors:  Théophile Ohlmann; Chloé Mengardi; Marcelo López-Lastra
Journal:  Translation (Austin)       Date:  2014-10-31

4.  Unexpected roles for UPF1 in HIV-1 RNA metabolism and translation.

Authors:  Lara Ajamian; Levon Abrahamyan; Miroslav Milev; Pavel V Ivanov; Andreas E Kulozik; Niels H Gehring; Andrew J Mouland
Journal:  RNA       Date:  2008-03-27       Impact factor: 4.942

5.  The double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidation.

Authors:  A J Mouland; J Mercier; M Luo; L Bernier; L DesGroseillers; E A Cohen
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

6.  hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer.

Authors:  F Del Gatto-Konczak; M Olive; M C Gesnel; R Breathnach
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Mov34 protein from mouse brain interacts with the 3' noncoding region of Japanese encephalitis virus.

Authors:  M Ta; S Vrati
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

8.  PSF acts through the human immunodeficiency virus type 1 mRNA instability elements to regulate virus expression.

Authors:  Andrei S Zolotukhin; Daniel Michalowski; Jenifer Bear; Sergey V Smulevitch; Abdulmaged M Traish; Rui Peng; James Patton; Ivan N Shatsky; Barbara K Felber
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  Human immunodeficiency virus type 1 (HIV-1) induces the cytoplasmic retention of heterogeneous nuclear ribonucleoprotein A1 by disrupting nuclear import: implications for HIV-1 gene expression.

Authors:  Anne Monette; Lara Ajamian; Marcelo López-Lastra; Andrew J Mouland
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

Review 10.  Mechanisms employed by retroviruses to exploit host factors for translational control of a complicated proteome.

Authors:  Cheryl Bolinger; Kathleen Boris-Lawrie
Journal:  Retrovirology       Date:  2009-01-24       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.